Hospitals Histogenics to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway byJosh SandbergSeptember 27, 2018
Biologics Histogenics Announces Top-Line Results From Phase 3 Clinical Trial of NeoCart® in Patients With Knee Cartilage Damage byJosh SandbergSeptember 6, 2018
Biologics Hospitals Histogenics Agreement With Japan Pharmaceuticals and Medical Devices Agency and Regulatory Pathway for NeoCart® byJosh SandbergMay 8, 2017
